Telitacicept Shows Efficacy, Safety in MTX-Resistant RA Telitacicept Shows Efficacy, Safety in MTX-Resistant RA

Telitacicept is a recombinant fusion protein that aims to target and neutralize B lymphocyte stimulator and a proliferation-inducing ligand (APRIL), both of which are linked to autoimmunity.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology Source Type: news
More News: Health | Rheumatology